期刊文献+
共找到760篇文章
< 1 2 38 >
每页显示 20 50 100
In situ subtotal spleen resection combined with selective pericardial devascularization for the treatment of portal hypertension 被引量:1
1
作者 Hai-Lin Li Shang-Lei Ning +2 位作者 Yan-Jing Gao Tao Zhou Yu-Xin Chen 《World Journal of Gastrointestinal Surgery》 SCIE 2023年第4期634-642,共9页
BACKGROUND Hypersplenism and esophageal varices bleeding are the major complications of portal hypertension(PHT).In recent years,increasing attention has been given to spleen preservation operations.The mode and long-... BACKGROUND Hypersplenism and esophageal varices bleeding are the major complications of portal hypertension(PHT).In recent years,increasing attention has been given to spleen preservation operations.The mode and long-term effects of subtotal splenectomy and selective pericardial devascularization for PHT remain controversial.AIM To investigate the clinical efficacy and safety of subtotal splenectomy combined with selective pericardial devascularization for the treatment of PHT.METHODS This was a retrospective study of 15 patients with PHT who underwent subtotal splenectomy not preserving the splenic artery or vein combined with selective pericardial devascularization in the Department of Hepatobiliary Surgery,Qilu Hospital of Shandong University from February 2011 to April 2022.Fifteen propensity score-matched patients with PHT who underwent total splenectomy at the same time served as the control group.The patients were followed for up to 11 years after surgery.We compared the postoperative platelet levels,perioperative splenic vein thrombosis,and serum immunoglobulin levels between the two groups.Abdominal enhanced computed tomography was used to evaluate the blood supply and function of the residual spleen.The operation time,intraoperative blood loss,evacuation time,and hospital stay were compared between the two groups.RESULTS The postoperative platelet level of patients in the subtotal splenectomy group was significantly lower than that in the total splenectomy group(P<0.05),and the postoperative portal system thrombosis rate in the subtotal splenectomy group was also much lower than that in the total splenectomy group.The levels of serum immunoglobulins(IgG,IgA,and IgM)showed no significant differences after surgery compared with before surgery in the subtotal splenectomy group(P>0.05),but serum immunoglobulin IgG and IgM levels decreased dramatically after total splenectomy(P<0.05).The operation time in the subtotal splenectomy group was longer than that in the total splenectomy group(P<0.05),but there were no significant differences in the amount of intraoperative blood loss,evacuation time,or hospital stay between the two groups.CONCLUSION Subtotal splenectomy not preserving the splenic artery or vein combined with selective pericardial devascularization is a safe and effective surgical treatment for patients with PHT,not only correcting hypersplenism but also preserving splenic function,especially immunological function. 展开更多
关键词 Subtotal splenectomy Portal hypertension Surgical treatment Splenic function Selective pericardial devascularization
下载PDF
Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding 被引量:1
2
作者 Wei-Li Qi Jun Wen +5 位作者 Tian-Fu Wen Wei Peng Xiao-Yun Zhang Jun-Yi Shen Xiao Li Chuan Li 《World Journal of Gastrointestinal Surgery》 SCIE 2023年第8期1641-1651,共11页
BACKGROUND Portal hypertension combined with esophagogastric variceal bleeding(EGVB)is a serious complication in patients with hepatitis B virus(HBV)-related cirrhosis in China.Splenectomy plus pericardial devasculari... BACKGROUND Portal hypertension combined with esophagogastric variceal bleeding(EGVB)is a serious complication in patients with hepatitis B virus(HBV)-related cirrhosis in China.Splenectomy plus pericardial devascularization(SPD)and transjugular intrahepatic portosystemic shunt(TIPS)are effective treatments for EGVB.However,a comparison of the effectiveness and safety of those methods is lacking.AIM To compare the prognosis after SPD vs TIPS for acute EGVB after failure of endoscopic therapy or secondary prophylaxis of variceal rebleeding(VRB)in patients with HBV-related cirrhosis combined with portal hypertension.METHODS This retrospective cohort study included 318 patients with HBV-related cirrhosis and EGVB who underwent SPD or TIPS at West China Hospital of Sichuan University during 2009-2013.Propensity score-matched analysis(PSM),the Kaplan-Meier method,and multivariate Cox regression analysis were used to compare overall survival,VRB rate,liver function abnormality rate,and hepatocellular carcinoma(HCC)incidence between the two patient groups.RESULTS The median age was 45.0 years(n=318;226(71.1%)males).During a median follow-up duration of 43.0 mo,18(11.1%)and 33(21.2%)patients died in the SPD and TIPS groups,respectively.After PSM,SPD was significantly associated with better overall survival(OS)(P=0.01),lower rates of abnormal liver function(P<0.001),and a lower incidence of HCC(P=0.02)than TIPS.The VRB rate did not differ significantly between the two groups(P=0.09).CONCLUSION Compared with TIPS,SPD is associated with higher postoperative OS rates,lower rates of abnormal liver function and HCC,and better quality of survival as acute EGVB treatment after failed endoscopic therapy or as secondary prophylaxis of VRB in patients with HBV-related cirrhosis combined with portal hypertension.There is no significant between-group difference in VRB rates. 展开更多
关键词 Portal hypertension Liver cirrhosis Esophagogastric variceal bleeding SPLENECTOMY pericardial devascularization Transjugular intrahepatic portosystemic shunt
下载PDF
Indocyanine green retention is a potential prognostic indicator after splenectomy and pericardial devascularization for cirrhotic patients 被引量:7
3
作者 Yuan-Biao Zhang Yi Lu +3 位作者 Wei-Ding Wu Cheng-Wu Zhang Guo-Liang Shen De-Fei Hong 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2016年第4期386-390,共5页
BACKGROUND:Splenectomy and pericardial devascularization(SPD)is an effective treatment of upper gastrointestinal bleeding and hypersplenism in cirrhotic patients with portal hypertension.Indocyanine green retention... BACKGROUND:Splenectomy and pericardial devascularization(SPD)is an effective treatment of upper gastrointestinal bleeding and hypersplenism in cirrhotic patients with portal hypertension.Indocyanine green retention at 15 minutes(ICGR15)was reported to offer better sensitivity and specificity than the Child-Pugh classification in hepatectomy,but few reports describe ICGR15 in SPD.The present study was to evaluate the prognostic value of ICGR15 for cirrhotic patients with portal hypertension who underwent SPD.METHODS:From January 2012 to January 2015,43 patients with portal hypertension and hypersplenism caused by liver cirrhosis were admitted in our center and received SPD.The ICGR15,Child-Pugh classification,model for end-stage liver disease(MELD)score,and perioperative characteristics were analyzed retrospectively.RESULTS:Preoperative liver function assessment revealed that 34 patients were Child-Pugh class A with ICGR15 of13.6%-43.0%and MELD score of 7-20;8 patients were class B with ICGR15 of 22.8%-40.7%and MELD score of 7-17;1patient was class C with ICGR15 of 39.7%and MELD score of 22.The optimal ICGR15 threshold for liver function compensation was 31.2%,which offered a sensitivity of 68.4%and a specificity of 70.8%.Univariate analysis showed preoperative ICGR15,MELD score,surgical procedure,intraoperative blood loss,and autologous blood transfusion were significantly different between postoperative liver function compensated and decompensated groups.Multivariate regression analysis revealed that ICGR15 was an independent risk factor of postoperative liver function recovery(P=0.020).CONCLUSIONS:ICGR15 has outperformed the Child-Pugh classification for assessing liver function in cirrhotic patients with portal hypertension.ICGR15 may be a suitable prognostic indicator for cirrhotic patients after SPD. 展开更多
关键词 indocyanine green liver function test liver cirrhosis splenectomy pericardial devascularization
下载PDF
Evaluation of the effects of combined endoscopic variceal ligation and splenectomy with pericardial devascularization on esophageal varices 被引量:7
4
作者 Bo Liu Mei-Hai Deng Nan Lin Wei-Dong Pan Yun-Biao Ling Rui-Yun Xu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第42期6889-6892,共4页
AIM: To detect the hemodynamic alterations in collateral circulation before and after combined endoscopic variceal ligation (EVL) and splenectomy with pericardial devascularization by ultrasonography, and to evaluate ... AIM: To detect the hemodynamic alterations in collateral circulation before and after combined endoscopic variceal ligation (EVL) and splenectomy with pericardial devascularization by ultrasonography, and to evaluate their effect using hemodynamic parameters. METHODS: Forty-three patients with esophageal varices received combined EVL and splenectomy with pericardial devascularization for variceal eradication. The esophageal vein structures and azygos blood flow (AZBF) were detected by endoscopic ultrasonography and color Doppler ultrasound. The recurrence and rebleeding of esophageal varices were followed up. RESULTS: Patients with moderate or severe varices in the esophageal wall and those with severe peri- esophageal collateral vein varices had improvements after treatment, while the percentage of patients with severe para-esophageal collateral vein varices decreased from 54.49% to 2.33%, and the percentage of patients with detectable perforating veins decreased from 79.07% to 4.65% (P < 0.01). Color Doppler flowmetry showed a significant decrease both in AZBF (43.00%, P < 0.05) and in diameter of the azygos vein (28.85%, P < 0.05), while the blood flow rate was unchanged. The recurrence rate of esophageal varices was 2.5% (1/40, mild), while no re-bleeding cases were recorded. CONCLUSION: EVL in combination with splenectomy with pericardial devascularization can block the collateral veins both inside and outside of the esophageal wall, and is more advantagious over splenectomy in combination with pericardial devascularization or EVL in preventing recurrence and re-bleeding of varices. 展开更多
关键词 Esophageal varices Endoscopic ultrasound Color Doppler ultrasonography Endoscopic variceal ligation splenectomy with pericardial devascularization
下载PDF
Laparoscopic versus Open Splenectomy and Devascularization for Massive Splenomegaly Due to Portal Hypertension 被引量:12
5
作者 Yao LIU Long ZHAO +4 位作者 Yong TANG Yu ZHANG Shen-chao SHI Fu-xiao XIE Chi-dan WAN 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2016年第6期876-880,共5页
Although the clinical benefit of laparoscopic splenectomy and devascularization(LSD) has been elaborated in many studies,its application in massive splenomegaly remains controversial.We conducted a retrospective res... Although the clinical benefit of laparoscopic splenectomy and devascularization(LSD) has been elaborated in many studies,its application in massive splenomegaly remains controversial.We conducted a retrospective research to assess the curative efficacy of LSD for massive splenomegaly due to portal hypertension.Forty-seven patients with massive splenomegaly due to portal hypertension were enrolled in this study,and divided into two groups.Twenty-one patients underwent open splenectomy and devascularization(OSD) from June 2010 to October 2012(OSD group).From March 2013 to February 2015,LSD was performed on 26 patients(LSD group).Perioperative variables were analyzed.Compared to OSD,LSD was associated with less blood loss(241.9±110.0 m L vs.319.0±139.5 m L,P〈0.05),more rapid resumption of oral diet(2.46±0.95 days vs.3.76±1.09 days,P〈0.05),and shorter postoperative hospital stay(5.35±1.65 days vs.7.24±1.55 days,P〈0.05).It was concluded that for patients with massive splenomegaly due to portal hypertension,LSD is feasible and as safe as OSD. 展开更多
关键词 massive splenomegaly portal hypertension LAPAROSCOPY SPLENECTOMY devascularization
下载PDF
Prevention and Treatment of Hemorrhage during Laparoscopic Splenectomy and Devascularization for Portal Hypertension 被引量:11
6
作者 王文静 唐勇 +1 位作者 张宇 陈庆 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2015年第1期99-104,共6页
This study was aimed to explore prevention and treatment of hemorrhage during laparoscopic splenectomy plus devascularization(LSD) for portal hypertension by modified and simplified operation. From June 2012 to June... This study was aimed to explore prevention and treatment of hemorrhage during laparoscopic splenectomy plus devascularization(LSD) for portal hypertension by modified and simplified operation. From June 2012 to June 2014, LSD was performed on 138 patients with portal hypertension. The patients were allocated into two groups: earlier stage(ES) group, in which 45 patients received traditional LSD from June 2012 to Sep. 2012; later stage(LS) group, in which 93 patients underwent modified LSD from Jan. 2013 to June 2014. Perioperative variables were compared between the two groups. Laparoscopic operations were successfully performed in all but two patients in ES group who were converted to laparotomy(total conversion rate: 1.4%). There was no perioperative death or reoperation, and all patients recovered and were discharged from hospital with no serious complications in the six months of postoperative follow-up. The average time in the ES group was longer than that in the LS group(335.1 min vs. 201.3 min, P〈0.05). LS group outperformed ES group in terms of blood loss(705.4 m L vs. 910.4 mL, P〈0.05). The average operation time to oral diet intake after surgery(40.5 h vs. 50.3 h, P〈0.05) and postoperative hospital stay(7.4 d vs. 9.0 days, P〈0.05) were much less in the LS group than in the ES group. The overall complication rate(4.3 % vs. 11.1 %, P〈0.05) and conversion rate(0% vs. 4.4%, P〈0.05) were lower in the LS group than in the ES group. It was concluded that prevention and treatment of hemorrhage are the key points of LSD for portal hypertension. By creating a tunnel above the splenic pedicle and a tunnel behind the lower esophagus, the simplified and modified LSD can reduce hemorrhage and improve success of surgery dramatically, and splenomegaly and severe varices are not contraindications. 展开更多
关键词 LAPAROSCOPY SPLENECTOMY devascularization HEMORRHAGE portal hypertension
下载PDF
Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding 被引量:21
7
作者 An-Ping Su Zhao-Da Zhang +1 位作者 Bo-Le Tian Jing-Qiang Zhu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2017年第2期169-175,共7页
BACKGROUND: Transjugular intrahepatic portosystemic shunt(TIPS) and open splenectomy and esophagogastric devascularization(OSED) are widely used to treat patients with portal hypertension and recurrent variceal b... BACKGROUND: Transjugular intrahepatic portosystemic shunt(TIPS) and open splenectomy and esophagogastric devascularization(OSED) are widely used to treat patients with portal hypertension and recurrent variceal bleeding(PHRVB). This study aimed to compare the effectiveness between TIPS and OSED for the treatment of PHRVB.METHODS: The data were retrospectively retrieved from 479 cirrhotic patients(Child-Pugh A or B class) with PHRVB, who had undergone TIPS(TIPS group) or OSED(OSED group) between January 1, 2010 and October 31, 2014.RESULTS: A total of 196 patients received TIPS, whereas 283 underwent OSED. Within one month after TIPS and OSED, the rebleeding rates were 6.1% and 3.2%, respectively(P=0.122). Significantly lower incidence of pleural effusion,splenic vein thrombosis, and pulmonary infection, as well as higher hepatic encephalopathy rate, shorter postoperative length of hospital stay, and higher hospital costs were observed in the TIPS group than those in the OSED group. During the follow-up periods(29 months), significantly higher incidences of rebleeding(15.3% vs 4.6%, P=0.001) and hepatic encephalopathy(17.3% vs 3.9%, P=0.001) were observed in the TIPS group than in the OSED group. The incidence of instent stenosis was 18.9%. The survival rates were 91.3% in the TIPS group and 95.1% in the OSED group. The long-term liver function did not worsen after either TIPS or OSED.CONCLUSION: For the patients with liver function in the Child-Pugh A or B class, TIPS is not superior over OSED in terms of PHRVB treatment and rebleeding prevention. 展开更多
关键词 liver cirrhosis portal hypertension recurrent variceal bleeding transjugular intrahepatic portosystemic shunt open splenectomy and esophagogastric devascularization
下载PDF
Esophagogastric devascularization without splenectomy in portal hypertension: safe and effective? 被引量:11
8
作者 Yan-Bin Ni Peng-Ji Gao +2 位作者 Dong Wang Zhao Li Ji-Ye Zhu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2015年第3期276-280,共5页
BACKGROUND: Esophagogastric variceal hemorrhage is a life-threatening complication of portal hypertension. In this study, we compared the therapeutic effect of a novel surgi- cal procedure, esophagogastric devascular... BACKGROUND: Esophagogastric variceal hemorrhage is a life-threatening complication of portal hypertension. In this study, we compared the therapeutic effect of a novel surgi- cal procedure, esophagogastric devascularization without splenectomy (EDWS), with the widely used modified esopha- gogastric devascularization (MED) with splenectomy for the treatment of portal hypertension. 展开更多
关键词 portal hypertension esophagogastric devascularization without splenectomy portal vein system thrombosis
下载PDF
Combined splenocaval or mesocaval C shunt and portoazygous devascularization in the treatment of portal hypertension: analysis of 150 cases 被引量:6
9
作者 Liu-Shun Feng and Xiao-Ping Chen Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2006年第1期70-73,共4页
BACKGROUND: Portal hypertension is a common disease and its major surgical therapeutic approaches include devascularization and shunting. This study was undertaken to investigate the effects of combined splenocaval or... BACKGROUND: Portal hypertension is a common disease and its major surgical therapeutic approaches include devascularization and shunting. This study was undertaken to investigate the effects of combined splenocaval or mesocaval C shunt and portoazygous devascularization (combined procedures) on portal hypertension. METHODS: The clinical data of 150 patients with portal hypertension who had undergone combined procedures at the First Affiliated Hospital of Zhengzhou University from May1990 to May 2003 were analyzed retrospectively. RESULTS: The mean free portal pressure (FPP) was 25.6±1.83 mmHg, 18.0±2.07 mmHg and 18.4±2.19 mmHg before operation, after splenectomy plus splenocaval or mesocaval C shunt, and combined procedures, respectively. There was no operative death in all patients. The 1-7 year follow-up of 100 patients showed rebleeding in 3 patients, encephalopathy in 4, thrombosis of artificial vascular graft in 3, and dying from liver failure in 2. CONCLUSIONS: The combined procedures can not only decrease portal pressure but also preserve hepatic blood flow to some extent. It may be one of the best choices for treating portal hypertension in China. 展开更多
关键词 HYPERTENSION portal vein blood vessel prosthesis devascularization SHUNTING
下载PDF
Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis 被引量:14
10
作者 Hong-ping LUO Zhan-guo ZHANG +4 位作者 Xin LONG Fei-long LIU Xiao-ping CHEN Lei ZHANG Wan-guang ZHANG 《Current Medical Science》 SCIE CAS 2020年第1期117-122,共6页
This study was conducted to compare the feasibility,safety and effectiveness of the combined-laparoscopic splenectomy and esophagogastric devascularization(C-LSED)with open splenectomy and esophagogastric devasculariz... This study was conducted to compare the feasibility,safety and effectiveness of the combined-laparoscopic splenectomy and esophagogastric devascularization(C-LSED)with open splenectomy and esophagogastric devascularization surgery(OSED)in patients with portal hypertension due to liver cirrhosis.From February 2014 to June 2018,68 patients with portal hypertension were diagnosed as having serious gastroesophageal varices and/or hypersplenism in our center.Thirty patients underwent C-LSED and 38 patients received OSED.Results and outcomes were compared retrospectively.No patients of C-LSED group required an intraoperative conversion to open surgery.Significantly shorter operating time,less blood loss,lower transfusion rates,shorter postoperative hospital stay,lower rates of complications were found in C-LSED group than in C-LSED group(P<0.05).No death and rebleeding were documented in both groups during the follow-up periods of one year Postoperative endoscopy revealed that varices in the patients of both groups were alleviated significantly from severe to mild,and in a part of cases,the varices disappeared.The final results suggest that the C-LSED technique is superior to open procedure,due to slightly invasive,simplified operative procedure,significantly shorter operating time,less intraoperative bleeding and lower post-operative complication rates.And C-LSED offers comparable long-term effects to open surgery. 展开更多
关键词 liver cirrhosis portal hypertension LAPAROSCOPY SPLENECTOMY esophagogastric devascularization
下载PDF
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization 被引量:47
11
作者 Wei Lai Shi-Chun Lu +5 位作者 Guan-Yin Li Chuan-Yun Li Ju-Shan Wu Qing-Liang Guo Meng-Long Wang Ning Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第26期3443-3450,共8页
AIM:To compare the incidence of early portal or splenic vein thrombosis(PSVT) in patients treated with irregular and regular anticoagulantion after splenectomy with gastroesophageal devascularization.METHODS:We retros... AIM:To compare the incidence of early portal or splenic vein thrombosis(PSVT) in patients treated with irregular and regular anticoagulantion after splenectomy with gastroesophageal devascularization.METHODS:We retrospectively analyzed 301 patients who underwent splenectomy with gastroesophageal devascularization for portal hypertension due to cirrhosis between April 2004 and July 2010.Patients were categorized into group A with irregular anticoagulation and group B with regular anticoagulation,respectively.Group A(153 patients) received anticoagulant monotherapy for an undesignated time period or with aspirin or warfarin without low-molecular-weight heparin(LMWH) irregularly.Group B(148 patients) received subcutaneous injection of LMWH routinely within the first 5 d after surgery,followed by oral warfarin and aspirin for one month regularly.The target prothrombin time/international normalized ratio(PT/INR) was 1.25-1.50.Platelet and PT/INR were monitored.Color Doppler imaging was performed to monitor PSVT as well as the effectiveness of thrombolytic therapy.RESULTS:The patients' data were collected and analyzed retrospectively.Among the patients,94 developed early postoperative mural PSVT,including 63 patients in group A(63/153,41.17%) and 31 patients in group B(31/148,20.94%).There were 50(32.67%) patients in group A and 27(18.24%) in group B with mural PSVT in the main trunk of portal vein.After the administration of thrombolytic,anticoagulant and antiaggregation therapy,complete or partial thrombus dissolution achieved in 50(79.37%) in group A and 26(83.87%) in group B.CONCLUSION:Regular anticoagulation therapy can reduce the incidence of PSVT in patients who undergo splenectomy with gastroesophageal devascularization,and regular anticoagulant therapy is safer and more effective than irregular anticoagulant therapy.Early and timely thrombolytic therapy is imperative and feasible for the prevention of PSVT. 展开更多
关键词 Portal vein hypertension Splenectomy withgastroesophageal devascularization Portal or splenicvein thrombosis Anticoagulation regimen Thrombo-lyric therapy
下载PDF
A Prospective Randomized Trial of Selective versus Nonselective Esophagogastric Devascularization for Portal Hypertension 被引量:3
12
作者 王超 肖亮 +3 位作者 韩娟 金常娥 彭音 杨镇 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2014年第4期563-568,共6页
Cirrhosis with portal hypertension is a common disease which has a significant impact on the quality of patients' life. Esophagogastric devascularization(EGDV) has been demonstrated to be an effective method to tre... Cirrhosis with portal hypertension is a common disease which has a significant impact on the quality of patients' life. Esophagogastric devascularization(EGDV) has been demonstrated to be an effective method to treat portal hypertension, however certain complications are associated with it. The purpose of this study was to evaluate the effectiveness and clinical outcome of the selective EGDV(sEGDV) for the treatment of portal hypertension. The study was conducted prospectively from Jan. 1 2011 to Dec. 31, 2012, and 180 patients were randomized to the sEGDV group(n=90) or the non-sEGDV(n-sEGDV) group(n=90). Patients' demographics, preoperative lab test results and operative details were comparable between the two groups. Postoperative and short-term complications were analyzed in two groups. There was statistically significant difference(P〈0.01) in the PVF reduction between the two groups. Post-operative complications showed no statistically significant difference between the two groups in the incidence of bleeding, ascites, acute portal vein thrombosis, fever and hepatic encephalopathy. Mortality between two groups was comparable. The incidence of splenic fossa effusion after the surgery was lower in sEGDV group than in n-sEGDV group. There were no significant differences in the short-term follow-up data such as esophageal varices and portal hypertensive gastropathy(P〉0.05). It is suggested that sEGDV is a safe, simple and effective surgical procedure. It has both the advantages of the shunt and devascularization because it preserves body's voluntary diversion. With the advantage of low incidence of postoperative complications, it is an ideal surgical approach for the treatment of portal hypertension. 展开更多
关键词 portal hypertension selective esophagogastric devascularization EFFICACY
下载PDF
失效模式与效应分析在食管胃底静脉曲张内镜下食管胃底静脉曲张精准断流术后患者中的应用效果 被引量:1
13
作者 潘泓 王春 《中国当代医药》 CAS 2024年第8期39-42,共4页
目的探究失效模式与效应分析在食管胃底静脉曲张内镜下食管胃底静脉曲张精准断流术(ESVD)后患者中的应用效果。方法选取2022年1月至11月九江学院附属医院收治的101例食管胃底静脉曲张ESVD后患者作为研究对象,采用随机数字表法分为对照组... 目的探究失效模式与效应分析在食管胃底静脉曲张内镜下食管胃底静脉曲张精准断流术(ESVD)后患者中的应用效果。方法选取2022年1月至11月九江学院附属医院收治的101例食管胃底静脉曲张ESVD后患者作为研究对象,采用随机数字表法分为对照组(50例)和观察组(51例)。对照组进行常规护理干预,观察组进行失效模式与效应分析为指导的护理干预。比较两组的住院时间、并发症发生率、满意度、护理干预前后的疼痛情况[数字评价量表(NRS)]及情绪状态[焦虑自评量表(SAS)及抑郁自评量表(SDS)]。结果观察组的住院时间短于对照组,并发症总发生率低于对照组,满意度高于对照组,差异有统计学意义(P<0.05);两组护理干预前的NRS评分、SAS评分及SDS评分比较,差异无统计学意义(P>0.05),观察组护理干预1、3、5 d的NRS评分、SAS评分及SDS评分低于对照组,差异有统计学意义(P<0.05)。结论失效模式与效应分析在食管胃底静脉曲张ESVD后患者中的应用效果较好,可缩短患者的住院时间及降低并发症发生率,同时对患者的疼痛及不良情绪也有较好的改善作用,更受患者认可。 展开更多
关键词 失效模式与效应分析 食管胃底静脉曲张 内镜下食管胃底静脉曲张精准断流术 并发症 住院时间 疼痛 情绪状态
下载PDF
Successful endoscopic treatment of superficial esophageal cancer in a patient with esophageal variceal bleeding:A case report
14
作者 Li Xu Shan-Shan Chen +1 位作者 Chao Yang Hai-Jun Cao 《World Journal of Clinical Cases》 SCIE 2024年第27期6105-6110,共6页
BACKGROUND The coexistence of esophageal variceal bleeding and superficial esophageal cancer(SEC)is relatively rare in clinical practice.Moreover,there have been few reports of SEC overlying esophageal varices(EVs).He... BACKGROUND The coexistence of esophageal variceal bleeding and superficial esophageal cancer(SEC)is relatively rare in clinical practice.Moreover,there have been few reports of SEC overlying esophageal varices(EVs).Herein,we report our successful use of endoscopic submucosal dissection(ESD),esophageal solitary venous dilatation(ESVD),and endoscopic injection sclerotherapy(EIS)to treat a 75-year-old man who was diagnosed with SEC coexisting with esophageal variceal bleeding.CASE SUMMARY A 75-year-old man was admitted to the hospital due to black stool for 4 days.The patient had a history of liver cancer,cirrhosis,and portal hypertension.Endosco-pic examination revealed esophageal and gastric varicose veins,as well as esoph-ageal carcinoma in situ.We first treated esophageal variceal bleeding by ESVD and EIS.One week later,ESD treatment was done,and the complete rese-ction of early esophageal cancer was successfully completed via endoscopy.There were no postoperative complications,such as bleeding,infection,or perforation.CONCLUSION The sequential treatment of ESVD,EIS,and ESD is an effective method for trea-ting EVs with early esophageal cancer. 展开更多
关键词 Endoscopic selective varices devascularization Endoscopic injection sclero-esophageal cancer Case report
下载PDF
腹腔镜脾切除联合贲门周围血管离断术治疗门静脉高压症的临床价值评估
15
作者 李虎 孟令展 +3 位作者 张晓峰 牛晓峰 庄云龙 朱震宇 《腹腔镜外科杂志》 2024年第5期336-341,共6页
目的:评估腹腔镜脾切除联合贲门周围血管离断术的优越性、安全性,以期为门静脉高压症手术治疗方案的选择提供依据。方法:回顾分析2017年3月至2021年11月收治的215例门静脉高压症患者的临床资料,其中研究组(n=68)行腹腔镜脾切除联合贲门... 目的:评估腹腔镜脾切除联合贲门周围血管离断术的优越性、安全性,以期为门静脉高压症手术治疗方案的选择提供依据。方法:回顾分析2017年3月至2021年11月收治的215例门静脉高压症患者的临床资料,其中研究组(n=68)行腹腔镜脾切除联合贲门周围血管离断术,从行开腹脾切除联合贲门周围血管离断术的患者中抽取68例作为对照组,比较两组围手术期相关指标、术后并发症等。结果:研究组手术时间长于对照组,术中出血量、术后住院时间、腹腔引流管留置时间、术后并发症均少于对照组,差异有统计学意义(P<0.05);两组术中自体血回输量差异无统计学意义(P>0.05)。结论:腹腔镜脾切除联合贲门周围血管离断术安全、效果显著,与传统开腹脾切除联合贲门周围血管离断术相比,具有创伤更小、术中容易暴露解剖间隙、康复快、住院时间短、并发症少的优点,值得推广应用。 展开更多
关键词 高血压 门静脉 贲门周围血管离断术 脾切除术 腹腔镜检查
下载PDF
腹腔镜脾动脉结扎联合贲门周围血管离断术治疗肝硬化门静脉高压症的回顾性研究
16
作者 赵肖累 谭磊 王晓波 《中国医学工程》 2024年第3期88-92,共5页
目的探讨腹腔镜脾动脉结扎(SAL)联合贲门周围血管离断术(EED)治疗肝硬化门静脉高压症(PHT)的治疗效果。方法回顾性研究2020年7月至2023年5月安阳市第三人民医院和安阳市第五人民医院收治的126例肝硬化PHT患者资料,根据不同手术方式分为... 目的探讨腹腔镜脾动脉结扎(SAL)联合贲门周围血管离断术(EED)治疗肝硬化门静脉高压症(PHT)的治疗效果。方法回顾性研究2020年7月至2023年5月安阳市第三人民医院和安阳市第五人民医院收治的126例肝硬化PHT患者资料,根据不同手术方式分为观察组(69例,行腹腔镜SAL术联合EED)和对照组[57例,行腹腔镜脾切除术(LS)联合EED]。比较两组患者围术期指标;比较术前及术后14 d血常规指标[血小板计数(PLT)、白细胞计数(WBC)、红细胞计数(RBC)]、肝功能指标[丙谷转氨酶(ALT)、谷草转氨酶(AST)、γ-谷氨酰转肽酶(GGT)]、凝血功能指标[活化部分凝血酶时间(APTT)、纤维蛋白原(FIB)、凝血原酶时间(PT)],观察两组患者术后并发症发生情况。结果观察组各项围术期指标均低于对照组(P<0.05);术后14 d,观察组PLT、WBC水平低于对照组(P<0.05),且RBC水平与对照组比较差异无统计学意义(P>0.05);观察组ALT、AST、GGT、APTT、PT水平低于对照组,FIB高于对照组(P<0.05);观察组术后并发症总发生率低于对照组(P<0.05)。结论腹腔镜SAL联合EED能提高治疗肝硬化PHT的手术效果,改善患者脾功能亢进,改善肝功能及凝血功能,降低并发症的发生。 展开更多
关键词 腹腔镜脾动脉结扎术 贲门周围血管离断术 肝硬化门静脉高压症
下载PDF
脾切除门奇静脉断流术后肝固有动脉及门静脉的血流动态变化特征 被引量:2
17
作者 赵晓飞 曾道炳 +3 位作者 栗光明 郭庆良 邸亮 丁兢 《临床肝胆病杂志》 CAS 北大核心 2023年第1期104-109,共6页
目的了解脾切除门奇静脉断流术后肝固有动脉、门静脉的血流动态变化规律。方法回顾性分析首都医科大学附属北京佑安医院2014年4月—2019年2月收治的103例门静脉高压症行脾切除门奇静脉断流术患者的临床资料,记录患者术前和术后1周、1个... 目的了解脾切除门奇静脉断流术后肝固有动脉、门静脉的血流动态变化规律。方法回顾性分析首都医科大学附属北京佑安医院2014年4月—2019年2月收治的103例门静脉高压症行脾切除门奇静脉断流术患者的临床资料,记录患者术前和术后1周、1个月、3个月、6个月、12个月、24个月肝固有动脉、门静脉血流动力学变化数据,进行术前和术后资料对比,分析术前和术后各时间点肝血流变化特征。计量资料符合正态分布时采用配对样本t检验分析术前、术后各指标的差异。结果脾切除门奇静脉断流术后1周、1个月、3个月、6个月、12个月、24个月患者门静脉内径、门静脉流量、门静脉最大流速和平均流速较术前显著下降(P值均<0.05);肝固有动脉流量、流速在术后1周及术后1个月较术前显著增加(P值均<0.05),术后3个月、6个月、12个月、24个月则与术前无显著差异(P值均>0.05)。结论脾切除门奇静脉断流术后门静脉内径、流速、流量较术前明显减低,肝固有动脉流速、流量在术后1个月内增加,术后3个月恢复至术前水平。 展开更多
关键词 肝硬化 高血压 门静脉 脾切除门奇静脉断流术 血流动力学
下载PDF
不同时机内镜下食管胃底静脉曲张精准断流术联合内镜下硬化术治疗食管胃底静脉曲张破裂出血的临床效果 被引量:3
18
作者 周文杰 项琪 +3 位作者 李江涛 李艳艳 刘金材 孙辉 《中国当代医药》 CAS 2023年第7期70-72,76,共4页
目的探讨不同时机内镜下食管胃底静脉曲张精准断流术(ESVD)联合内镜下硬化术(EIS)治疗食管胃底静脉曲张破裂出血的临床效果与安全性。方法回顾性分析2020年7月至2021年6月于九江市第一人民医院治疗的60例肝硬化合并食管胃底静脉曲张破... 目的探讨不同时机内镜下食管胃底静脉曲张精准断流术(ESVD)联合内镜下硬化术(EIS)治疗食管胃底静脉曲张破裂出血的临床效果与安全性。方法回顾性分析2020年7月至2021年6月于九江市第一人民医院治疗的60例肝硬化合并食管胃底静脉曲张破裂出血患者的临床资料,所有患者均行ESVD联合EIS治疗,将其中于发病后6~<12 h进行治疗的32例患者纳入A组,将于发病后12~24 h进行治疗的28例患者纳入B组,所有患者术后均随访1年。比较两组患者治疗后3个月的临床疗效、两组患者随访期间再出血率(早期再出血率、迟发性再出血率、总再出血率)以及术后并发症发生率。结果治疗后3个月A组的临床疗效高于B组,差异有统计学意义(P<0.05);随访期间A组的总再出血率低于B组,差异有统计学意义(P<0.05);术后两组患者的并发症发生率比较,差异均无统计学意义(P>0.05)。结论对于食管胃底静脉曲张破裂出血患者,于发病后早期采取ESVD联合EIS手术方案的临床疗效显著,能降低患者的总再出血率,且安全性良好。 展开更多
关键词 不同时机 内镜下食管胃底静脉曲张精准断流术 内镜下硬化术 食管胃底静脉曲张破裂出血
下载PDF
Crosslinking of Bovine Pericardia Using Procyanidins
19
作者 WAN Rong-xin TIAN Cong +1 位作者 GU Han-qing LIU Xin 《Chinese Journal of Biomedical Engineering(English Edition)》 2011年第2期83-89,共7页
The aim of this study was to evaluate the crosslinking effect of a naturally crosslinking reagent-procyanidins (PA)-on the materials of bioprosthetic heart valves. After fixing bovine pericardial tissues by procyani... The aim of this study was to evaluate the crosslinking effect of a naturally crosslinking reagent-procyanidins (PA)-on the materials of bioprosthetic heart valves. After fixing bovine pericardial tissues by procyanidins, crosslikng characteristics, mechanical properties, in vitro enzymatic degradation resistance, the hydrophilicity and hemolysis tests were examined. The results showed that the fixation of biological tissue with glutaraldehyde (GA) or procyanidins increased its denaturation temperature, the surface hydrophilieity and mechanical properties as well as in vitro enzymatic degradation resistance. There were no significant differences in denaturation temperature, mechanical properties, the hydrophilicity and the in vitro enzymatic degradation between the glutaraldehyde and procyanidins fixed tissues. However, the ultimate tensile strength of the procyanidins fixed tissues was significantly superior to the glutaraldehyde fixed tissues. The hemolysis tests showed that hemolysis rate of the proeyanidins fixed tissues was lower than that of the glutaraldehyde fixed tissues. This study shows that procyanidins can crosslink which bovine pericardiaa effectively without toxicity. Our results suggest that this method might be a useful approach for the preparation of bioprosthetic heart valve. 展开更多
关键词 bovine pericardia bioprosthetic heart valves GLUTARALDEHYDE PROCYANIDINS
下载PDF
上一页 1 2 38 下一页 到第
使用帮助 返回顶部